Emergent BioSolutions, Inc. (EBS)
8.23
-0.15
(-1.79%)
USD |
NYSE |
Apr 02, 16:00
8.22
-0.01
(-0.12%)
After-Hours: 20:00
Emergent BioSolutions Research and Development Expense (TTM) : 53.80M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Eli Lilly & Co. | 13.34B |
| Penumbra, Inc. | 83.18M |
| Disc Medicine, Inc. | 170.36M |
| MetaVia, Inc. | 6.802M |